Women's Hormone Therapy & BHRT in Encinitas

Many of the symptoms that bring women in for hormone evaluation are ones they have been living with for months — or years — assuming they are just "getting older." Some of these symptoms do have other causes, and a good evaluation rules those out. But hormonal changes during perimenopause and menopause are one important consideration, and they are among the most treatable.

Women commonly seek evaluation for:

• Hot flashes and night sweats
• Waking during the night, insomnia or unrefreshing sleep
• Fatigue that doesn't resolve with rest
• Brain fog and difficulty concentrating
• Mood changes and irritability
• Low libido and other sexual changes
• Vaginal dryness or painful intercourse
• Changes in body composition — increased abdominal fat, loss of muscle or strength
• Hair thinning and skin changes
• Bone-health concerns

None of these symptoms automatically means hormones are the cause — but together, especially around the midlife transition, they are a strong reason to check. Learn more about the symptoms and stages of perimenopause and menopause.

For years, many women were discouraged from considering hormone therapy because findings from the Women's Health Initiative were broadly applied to women of very different ages and stages of menopause. The FDA has now updated menopausal hormone therapy labeling to better reflect the evidence in women who begin treatment closer to menopause.

Here is what happened, in plain terms:

• November 2025: After a comprehensive literature review, an expert panel and a public comment period, the FDA requested major labeling changes for menopausal hormone therapy products — including removal of boxed-warning language concerning cardiovascular disease, breast cancer and probable dementia.
• February 2026: The FDA approved the first updated labels reflecting these changes, spanning all four categories of menopausal hormone therapy — systemic combination therapy, systemic estrogen-alone, systemic progestogen-alone, and topical vaginal estrogen.
• The "lowest dose, shortest time" instruction is gone. The FDA also requested removal of the previous boxed-warning instruction to use hormone therapy at the lowest effective dose for the shortest duration.
• One boxed warning remains: the endometrial-cancer warning stays in place for systemic estrogen-alone therapy — which is exactly why progesterone is used alongside estrogen for women who have a uterus.

For systemic therapy, current FDA labeling specifically considers women younger than 60 or within 10 years of menopause onset — often referred to as the "timing hypothesis" or therapeutic window. The FDA states that randomized studies show women who initiate hormone replacement therapy within 10 years of menopause onset — generally before age 60 — have demonstrated reductions in all-cause mortality and fractures.

What this does not mean is that hormone therapy is right for every woman, or that it carries no risks. It means the old one-size-fits-all warning no longer reflects the evidence, and that timing matters. The decision is still an individualized one between you and your prescriber — based on your symptoms, age, time since menopause onset, medical history and treatment goals. That conversation is exactly how we practice at Better Off.

Perimenopause is often misunderstood because it is not a single event — it is a transition that can begin years before the final menstrual period. During this time, hormone levels fluctuate rather than declining in a straight line, which is why symptoms can come and go, and why two women at the same stage can feel completely different.

Women in perimenopause commonly notice:

• Cycle changes — shorter, longer, heavier or more unpredictable periods
• Sleep disruption, including waking at night
• Hot flashes and night sweats
• Mood changes, irritability or anxiety
• Brain fog and difficulty concentrating
• Changes in libido
• Fatigue that doesn't match activity level
• Early body-composition changes, especially around the midsection

Perimenopause hormone therapy is individualized — and it evolves. A plan that works at 44 may need adjustment at 47 as hormone patterns shift. Some women in perimenopause are treated with hormonal contraception or cyclic progesterone; others are candidates for estradiol-based therapy; some need testosterone as well. Treatment decisions account for whether you still have periods, your contraceptive needs, your uterus status and your symptom picture. Our Menopause & Perimenopause guide covers the stages and symptom picture in depth.

Menopause — defined as 12 consecutive months without a period — marks the end of ovarian follicular function, and with it the steady production of estradiol. Progesterone production falls alongside it. Testosterone also declines with age, though more gradually.

The consequences reach well beyond hot flashes:

• Vasomotor symptoms — hot flashes and night sweats are the classic presentation, and estradiol remains the most effective treatment available for them.
• Vaginal and urinary symptoms — dryness, irritation, painful intercourse and recurrent urinary symptoms are common and highly treatable, with systemic or localized estrogen depending on the picture.
• Sleep — night sweats disrupt sleep directly, and hormonal changes affect sleep architecture even without them.
• Sexual health — desire, arousal and comfort can all change; estradiol and, where appropriate, testosterone both play roles.
• Bone health — estrogen decline accelerates bone loss; menopause hormone therapy is one of the most effective ways to protect bone density during this transition.
• Muscle and body composition — losing estrogen shifts fat distribution and makes muscle harder to hold onto.
• Quality of life — mood, cognition and energy often improve when the underlying hormonal drivers are treated, rather than each symptom chased separately.

There is no single hormone regimen that fits every woman. The right plan depends on your symptoms, your labs, whether you have a uterus, your health history and risk profile, and what matters most to you. Treatment is then adjusted based on how you respond.

Estradiol is the primary estrogen in premenopausal women and the hormone most often replaced during and after the menopause transition. It is far more than a hot-flash medication — estradiol receptors are distributed throughout the body:

• Temperature regulation — estradiol is the most effective treatment for hot flashes and night sweats.
• Vaginal and urinary tissues — it maintains tissue elasticity, moisture and urinary tract health.
• Bone — it restrains bone resorption; deficiency accelerates bone loss.
• Sleep — directly and through relief of night sweats.
• Mood — estradiol modulates neurotransmitter systems involved in mood regulation.
• Sexual health — desire, arousal, comfort and tissue integrity.
• Systemic effects — skin collagen, blood vessels, lipid metabolism and cognitive function all respond to estrogen signaling.

Estradiol can be delivered several ways: as estradiol pellets placed during a brief office visit, as transdermal patches, as creams or gels, or in other formulations as clinically appropriate. Route selection depends on the patient, the dose, health history and preference — we review the options at your evaluation.

Progesterone follows a different pattern than estradiol. In a cycling woman it rises after ovulation and falls before the period; during perimenopause, ovulation — and therefore progesterone production — becomes irregular, often before estradiol falls. That imbalance is part of why perimenopause can feel so different from month to month.

In women's hormone therapy, progesterone has two main roles:

• Endometrial protection. For any woman with a uterus using systemic estrogen, progesterone protects the uterine lining. This is not optional — unopposed estrogen increases endometrial cancer risk, which is why the FDA's boxed warning remains on estrogen-alone products.
• Sleep and mood. Many women — and a meaningful body of research — support a calming, sleep-promoting effect from oral micronized progesterone, which is why we often dose it at bedtime.

One point of clarity for pellet patients: in our program, progesterone is generally managed separately — most often as an oral micronized capsule at bedtime — rather than implanted as a pellet. That keeps the estradiol (and testosterone, where used) in the pellet for sustained delivery while progesterone dosing stays flexible.

Testosterone is usually framed as a male hormone, but women produce it throughout life — from the ovaries and adrenal glands — and it plays a real role in female health. Women need far lower levels than men, but lower does not mean unimportant.

Where clinically relevant, testosterone in women can matter for:

• Libido — desire is one of the best-supported indications for testosterone therapy in women.
• Sexual function — arousal, responsiveness and satisfaction.
• Muscle and strength — testosterone contributes to lean mass maintenance.
• Energy — persistent fatigue that doesn't match lifestyle.
• Motivation and drive — the "flat" feeling some women describe.
• Body composition — fat distribution and metabolic health.
• Sense of well-being — where deficiency is part of the picture.

Testosterone therapy for women is individualized — dosed appropriately for female physiology, guided by symptoms and laboratory findings, and monitored over time. It can be delivered as testosterone pellets for women alongside estradiol, or through other routes depending on the plan. Our Hormone Optimization hub explains how testosterone fits into hormone care for women and men, and our Testosterone Therapy page covers how evaluation and monitoring work — the same careful process applies whether the patient is male or female.

Hormone pellets are one of the delivery options many of our female BHRT patients prefer. A pellet is a very small compressed implant of bioidentical hormone — about the size of a grain of rice — placed just beneath the skin during a brief office procedure, where it releases hormone gradually over months.

For women, pellet therapy typically involves:

• Estradiol pellets — the backbone of menopause hormone therapy for many patients.
• Testosterone pellets for women — added where clinically appropriate, in female-appropriate dosing.

The appeal is practical: sustained hormone delivery over time, no daily cream or pill to remember, and longer intervals between treatments. Women are commonly re-pelleted approximately every 3–4 months, though the interval is always guided by symptoms, labs and individual metabolism rather than a fixed calendar. Dosing is individualized at every insertion — based on your symptoms, hormone levels, prior dose and clinical response — and follow-up laboratory testing confirms the plan is working.

At Better Off, we pellet many women who prefer sustained hormone delivery and fewer daily medication routines. Learn more about hormone pellet therapy for women and men.

Pellets are a favorite for good reason, but they are not automatically right for every woman — and the hormone being treated, your history, your preferences, your response and your goals all matter.

Option	How it works	Practical notes
Hormone pellets	Bioidentical estradiol and/or testosterone implants placed under the skin during a brief office visit	Sustained delivery over months; no daily routine; women commonly re-pelleted about every 3–4 months; dose changes happen at the next insertion
Patches	Transdermal estradiol on a set schedule	Steady absorption without daily application; scheduled changes; adhesive irritates some patients
Creams and gels	Transdermal delivery applied at home	Usually regular home application; small dose adjustments possible; skin-contact transfer to others must be avoided
Oral medications	Taken by mouth — most commonly micronized progesterone	Useful for certain hormones and patients; liver processing matters for some risk profiles
Testosterone injections	Where appropriate for certain patients	Flexible dosing schedules; less commonly used for women than pellets

Route selection is a clinical decision we make with you, not a default. Explore all hormone therapy options at Better Off.

Sexual symptoms are among the most common — and least discussed — reasons women seek hormone care. Hormonal changes can affect every part of the picture:

• Low libido — desire often falls with estradiol and testosterone changes, stress, sleep loss and certain medications.
• Vaginal dryness — estrogen maintains vaginal tissue moisture and elasticity; decline causes dryness and irritation, and it is highly treatable with systemic or localized estrogen.
• Discomfort with intercourse — usually a consequence of tissue changes, and one of the symptoms that responds most reliably to treatment.
• Changes in arousal and responsiveness — where testosterone deficiency is part of the picture, addressing it can help.

It's important to be honest about one thing: sexual symptoms can have multiple contributing factors — relationship dynamics, stress, sleep, mood, medications and medical conditions all matter. Hormone evaluation is one part of the overall assessment, not the whole story. But when hormones are a driver, treating them changes the picture in a way that nothing else will.

The menopause transition changes body composition in ways that diet and exercise alone often can't fully explain:

• Muscle mass and strength decline as estrogen and testosterone fall, making muscle harder to build and easier to lose.
• Fat distribution shifts toward the abdomen — a metabolic change, not a willpower failure.
• Metabolic health can shift with it: insulin sensitivity, lipids and energy expenditure all respond to sex-hormone signaling.
• Bone density falls fastest in the years around menopause; estrogen deficiency accelerates bone resorption, and hormone therapy is one of the most effective protections available during this window.

This is why treating weight alone misses the point. The whole picture — hormones, protein intake, resistance training, sleep and metabolic health — has to be considered together, because they interact. Our Body Composition & Muscle Loss guide goes deeper on how we approach these changes.

Hormonal shifts can contribute to hair thinning and changes in hair texture, skin dryness, and loss of collagen and elasticity — estradiol supports skin collagen and moisture, and androgen changes affect hair follicles. Hormones are one contributor among several (genetics, thyroid, iron and stress all matter), and treating the hormonal piece works best as part of a full evaluation. Our Hair Loss & Thinning guide covers how we evaluate and treat thinning hair in women.

Women's hormone therapy at Better Off follows the same careful sequence for every patient:

1. Review symptoms and health history — what you're experiencing, when it started, your medical and family history, medications and prior hormone treatment.
2. Review menstrual and menopause stage — where you are in the transition changes both the interpretation of labs and the treatment options.
3. Laboratory testing — hormone levels and other clinically relevant markers, interpreted alongside your symptoms rather than in isolation.
4. Discuss hormone options — which hormones make sense for you, what each one does, and what it doesn't.
5. Choose route and dosing — pellets, patches, creams, oral or combinations, at doses individualized to you.
6. Follow-up labs and symptom review — confirming the plan is doing what it should, safely.
7. Adjust treatment over time — hormones, doses, routes and intervals change as your body and life change.

Hormone treatment is not simply based on one lab number. A single value drawn on a single day rarely tells the whole story — symptoms, history, levels and response are considered together, at every step.

Female hormone testing is the backbone of responsible hormone care — before treatment and throughout it.

• Baseline labs before starting therapy establish where you are: hormone levels plus other clinically relevant markers depending on your history.
• Follow-up hormone labs after starting (or after a dose change) confirm levels are where we want them and that your body is responding.
• Symptom response is tracked alongside numbers — labs inform the plan, but how you feel is part of the data too.
• Safety monitoring relevant to your specific therapy and history is built into follow-up.
• Treatment timing — including when the next pellet is due or when a dose should change — is guided by both labs and symptoms.
• Dose adjustment happens over time as your response and life stage change.

There is no universal rigid lab schedule — testing varies by patient and therapy, and we set expectations for timing at your evaluation. What doesn't vary: hormone therapy at Better Off is monitored care, not insert-and-forget.

Better Off regularly welcomes women who have been receiving hormone treatment elsewhere — hormone pellets, estradiol, progesterone, testosterone, patches, creams or gels, or other established hormone regimens. Whether you're moving to the area, your previous prescriber has retired, or you simply want a provider who will look at your whole picture, continuity of care is something we do well.

If you already receive hormone therapy, we use your prior treatment history, laboratory results and response as the starting point for understanding your ongoing care. Helpful records to bring:

• Previous hormone doses — estradiol, progesterone, testosterone
• Medication names and formulations
• Pellet insertion dates, if applicable
• Recent hormone labs
• How you responded to prior treatment — what improved, what didn't, any side effects
• Current prescriptions, including progesterone use

Don't have records on hand? That's not a barrier. We can establish baseline labs and a full history ourselves — prior information simply helps us move faster and with more context.

Transfer Your Hormone Care →  Book a Hormone Consultation →

Better Off provides women's hormone replacement therapy, BHRT and hormone pellet therapy at our Encinitas clinic for patients throughout San Diego County. We frequently see women from nearby communities including Olivenhain, Rancho Santa Fe, Cardiff-by-the-Sea, Carlsbad, Solana Beach, Del Mar and Leucadia, as well as patients traveling from elsewhere in the county — including Oceanside, Vista and San Marcos and beyond — for individualized hormone management.

What draws patients to us isn't proximity alone. It's that hormone care done properly takes time: a real evaluation, labs interpreted in context, dosing individualized to you, and a provider who adjusts the plan as your response and life stage change. If you've been looking for a hormone doctor in Encinitas or anywhere in San Diego County who treats hormone therapy as monitored medicine rather than a menu of products, that's exactly how we practice.

• Hormone Optimization — our hormone hub: testing, delivery options and ongoing management for women and men.
• Hormone Pellet Therapy — sustained hormone delivery for women and men who prefer fewer medication routines.
• Menopause & Perimenopause — a deeper guide to hormonal changes, symptoms and treatment considerations for women.
• Hormone Therapy: What the Evidence Actually Shows — for patients who want a deeper look at the research behind hormone therapy, including the FDA's 2025–2026 labeling changes.
• Testosterone Therapy — evaluation and monitored treatment for testosterone deficiency; testosterone is part of hormone care for both men and women.
• Hair Loss & Thinning — evaluation and treatment options when thinning hair is part of the picture.